In conclusion, this study has demonstrated the suppressive function of KLF15/TFAP2A-AS1/miR-3657/NISCH axis in GC cells, which offers a novel potential mechanism for being targeted in the treatment of GC. This evidence concerns the gene KLF15 and gastric cancer.